Skip to main content
Delfa

Lead sponsor

University of Colorado, Denver

15 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.

15

Trials led

8

Ongoing

964

Total enrollment

5

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1
1
Phase 1/2
1
Phase 2
2
Phase 2/3
3
Phase 3
3
Phase 4
1
Not applicable
4

Trials by status

Not yet recruiting
2
Recruiting
6
Completed
6
Withdrawn
1

Trials led

Focusing on the Menopausal Transition to Improve Mid-Life Women's HealthFemalePh 2/3Recruiting200
Glucagon-Like Peptide-1 Receptor Agonist in ADPKDBMI ≥27Ph 2Recruiting126
PLASTIC-Ph 3Not yet recruiting120
APPLEFemalePh 2/3Completed92
RESTOREFemalePh 3Recruiting80
SIBBMI ≥28Ph 4Completed69
T1-DISCOBMI 20-45Ph 3Recruiting60
TEALFemalePh 2/3Completed60
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)BMI ≥25Ph 2Completed50
PRESSURE-Ph 1Recruiting40
ExenatideBMI ≤35not applicableCompleted23
Effects of GLP-1 RAs on Human Lactation OutcomesFemalenot applicableRecruiting18
Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.BMI 30-45not applicableNot yet recruiting16
Pramlintide in Adolescents With Type 1 DiabetesHbA1c 7.5-10%not applicableCompleted10
Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus-Ph 1/2Withdrawnnot disclosed